Related references
Note: Only part of the references are listed.Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8(+) T cell responses against HPV16 oncoproteins
Nicolas Cuburu et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV plus tumors
Sumit Mukherjee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
A study of treatments and outcomes in elderly women with cervical cancer
Kumi Shimamoto et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
Current research into novel therapeutic vaccines against cervical cancer
Marcelo Nazario Cordeiro et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy
Petr O. Ilyinskii et al.
PLOS ONE (2018)
HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
Sergio Menezes Amaro-Filho et al.
PAPILLOMAVIRUS RESEARCH (2018)
A Karnofsky Performance Status-Based Score Predicts Death After Hospital Discharge in Patients With Cirrhosis
Puneeta Tandon et al.
HEPATOLOGY (2017)
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
Paola Di Bonito et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Elevated HPV16 E1 Expression Is Associated with Cervical Cancer Progression
Fern Baedyananda et al.
INTERVIROLOGY (2017)
Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation
Suruchi Mittal et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2017)
Breadth of T Cell Responses After Immunization with Adenovirus Vectors Encoding Ancestral Antigens or Polyvalent Papillomavirus Antigens
E. Ragonnaud et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era
Vicki B. Benard et al.
JAMA ONCOLOGY (2017)
Cancer incidence and mortality in China, 2013
Wanqing Chen et al.
CANCER LETTERS (2017)
Global Cancer in Women: Burden and Trend
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer
J. McLachlan et al.
CLINICAL ONCOLOGY (2017)
Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
Daniel C. Beachler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
F. Xavier Bosch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
Daniel C. Beachler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Design of peptides as inhibitors of human papillomavirus 16 transcriptional regulator E1-E2
Worrapon Kantang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Current state in the development of candidate therapeutic HPV vaccines
Andrew Yang et al.
EXPERT REVIEW OF VACCINES (2016)
Multilayered HIV-1 gag-specific T-cell responses contribute to slow progression in HLA-A*30-B*13-C*06-positive patients
Hui Zhang et al.
AIDS (2015)
Cervical Cancer Screening Among Adult Women in China, 2010
Baohua Wang et al.
ONCOLOGIST (2015)
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2015)
Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design
Agnieszka K. Grabowska et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The Cell Cycle Timing of Human Papillomavirus DNA Replication
Tormi Reinson et al.
PLOS ONE (2015)
Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer
Osama E. Rahma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
The human papillomavirus family and its role in carcinogenesis
Massimo Tommasino
SEMINARS IN CANCER BIOLOGY (2014)
Enzyme-linked immunospot assay response to recombinant CFP-10/ESAT-6 fusion protein among patients with spinal tuberculosis: implications for diagnosis and monitoring of surgical therapy
Kai Yuan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CU responses
Masahito Mizuuchi et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Share Paper
